PRODUCT INNOVATION. PATIENT IMPACT.

Serial Number 97638112
730

Registration Progress

Application Filed
Oct 19, 2022
Under Examination
May 7, 2024
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered

Trademark Image

PRODUCT INNOVATION. PATIENT IMPACT.

Basic Information

Serial Number
97638112
Filing Date
October 19, 2022
Published for Opposition
March 12, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
May 9, 2025
Application
Pending
Classes
005

Rights Holder

SUN PHARMACEUTICAL INDUSTRIES, INC.

03
Address
2 INDEPENDENCE WAY
PRINCETON, NJ 08540

Ownership History

Concert Pharmaceuticals, Inc.

Original Applicant
03
Lexington, MA

SUN PHARMACEUTICAL INDUSTRIES, INC.

New Owner Before Publication #1
03
PRINCETON, NJ

SUN PHARMACEUTICAL INDUSTRIES, INC.

Owner at Publication
03
PRINCETON, NJ

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description Documents
May 12, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 9, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 7, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 7, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
May 7, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 29, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 29, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 26, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 26, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 26, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 26, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 26, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 1, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Nov 1, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Aug 2, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 2, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 2, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 2, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 14, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 2, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 22, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
A full line of pharmaceuticals, namely, pharmaceutical preparations for the treatment of alopecia, cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification

International Classes
005